Skip to main content
Clinical Trials/NCT02428621
NCT02428621
Terminated
Not Applicable

Prospective Multicentric, Open-label, Randomized Study Assessing the Efficacy of the Removable and Adjustable Preformed Twicare® Appliance Versus Removable Herbst Appliance Treatment in Class II Malocclusion

FCI System2 sites in 1 country62 target enrollmentJuly 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Malocclusion, Angle Class II, Division 1
Sponsor
FCI System
Enrollment
62
Locations
2
Primary Endpoint
A point-nasion-B point (ANB) angle change
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

The aim of this prospective, multicentric, randomized, open-label study is to assess the efficacy of the removable Twicare® as mandibular propulsive appliance in children aged from 7 to 12 years old in the course of their orthodontic treatment, showing its noninferiority with the removable Herbst. One untreated group will be included to control the internal validity of the study as recommend in noninferiority trials. Patients will have a follow-up every two months during 6 to 12 months as planned in routine care.

Detailed Description

A large number of functional appliances, mandibular advancement activators with various designs, fixed or removable, are used in Class II malocclusion correction; one of the largest means being used is the Herbst. These appliances can be individualized, made to measure by the prosthetist or standardised (on market). A new medical device, EC marked and marketed since 2011, the Twicare®, can be used as positioner, growth activator, but also for lingual re-education. There are numerous publications comparing the activators' effects or the appliance effects on mandibular growth, but none have studied the Twicare®. The aim of this study is to assess the efficacy of this specific removable appliance in mandibular advancement in Class II skeletal in children aged from 7 to 12 years old. The appliance will be compared with the Herbst and one untreated group will be included to control the internal validity of the study as recommend in noninferiority trials. Patients will have a follow-up every two months during 6 to 12 months until the Class I occlusion is achieved. A lateral cephalogram and a dental silicon impression will be performed at the beginning (T0) and at the end of the treatment (T1) in order to evaluate cephalometric measurement changes, ANB, overjet and canine and molar class evolutions. The data collected at the beginning and at the end of the treatment will be analyzed and compared aware from patient, treatment and time, in order to assess the Twicare® noninferiority compared to the Herbst and to confirm the superiority of these two appliances versus observation. We will study, in parallel, the nasal ventilator function as well as comfort, compliance, tolerance and acceptability of the device via an auto-questionnaire.

Registry
clinicaltrials.gov
Start Date
July 2015
End Date
October 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
FCI System
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children with Class II division 1 malocclusion
  • Overjet ≥ 4 mm,
  • ANB \> 4°,
  • Good cooperation (motivation and good dental hygiene),
  • Incisors width compatible with the available Twicare® appliance sizes, according to the manufacturer recommendations.
  • Written Informed Consent of the Child,
  • Affiliated to health insurance,
  • Parents able to receive informed consent and to express their approval for their child to take part in this investigation.

Exclusion Criteria

  • Non well-balanced periodontal disease,
  • Temporal-mandibular dysfunction,
  • Severe bruxism noctural episodes,
  • Known allergy or intolerance to one of the activators' components.
  • Foreseeable follow-up difficulties,
  • Minor under guardianship,
  • Simultaneous participation to an interventional study.

Outcomes

Primary Outcomes

A point-nasion-B point (ANB) angle change

Time Frame: 6-12 months

ANB change is measured in lateral cephalograms between the beginning (T0) and the end (T1) of the treatment.

Secondary Outcomes

  • Cephalometric analysis (Tweed analysis of lateral cephalograms)(6-12 months)
  • Nasal ventilation (Peak Nasal Inspiratory Flow (PNIF) change)(6-12 months)
  • Compliance (appliance wearing based on patient interview with a questionnaire.)(6-12 months)
  • Overjet change using dental silicone impression(6-12 months)
  • Treatment acceptability (subjective)(6-12 months)

Study Sites (2)

Loading locations...

Similar Trials